Development and characterization of a naturally derived lung extracellular matrix hydrogel

Journal of Biomedical Materials Research - Part A

Volumn 104, Issue 8, 2016, Pages 1922-1935

  Pouliot, Robert A ^a   Link, Patrick A ^a   Mikhaiel, Nabil S ^a   Schneck, Matthew B ^a   Valentine, Michael S ^a   Kamga Gninzeko, Franck J ^a   Herbert, Joseph A ^a   Sakagami, Masahiro ^b   Heise, Rebecca L ^a,b  

^a Virginia Commonwealth University   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

decellularized lung; extracellular matrix; hydrogel; mesenchymal stem cells; rheometry

Indexed keywords

BIOLOGICAL ORGANS; BIOMECHANICS; CELL CULTURE; CHARACTERIZATION; FLOWCHARTING; RATS; SELF ASSEMBLY; STEM CELLS; TISSUE;

CONCENTRATION-DEPENDENT; DECELLULARIZED; DECELLULARIZED TISSUES; EXTRACELLULAR MATRICES; HUMAN MESENCHYMAL STEM CELLS; MESENCHYMAL STEM CELL; RHEOLOGICAL CHARACTERIZATION; RHEOMETRY;

HYDROGELS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ENCAPSULATION; CELL GROWTH; CELL VIABILITY; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CONTROLLED STUDY; DECELLULARIZATION; EMPHYSEMA; EXTRACELLULAR MATRIX; FLOW MEASUREMENT; HUMAN; HUMAN CELL; HYDROGEL; LUNG PARENCHYMA; MESENCHYMAL STEM CELL; NONHUMAN; PROTEIN SECRETION; STORAGE;

EID: 85027918616     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35726     Document Type: Article

References (57)

1. Kochanek KD, Xu J, Murphy SL, Miniño AM, Kung HC. National vital statistics reports. Natl Vital Stat Rep 2011;59:1.
2. Olsson B, Bondesson E, Borgstrom L, Edsbacker S, Eirefelt S, Ekelund K, Gustavsson L, Hegelund-Myrback T. In Smyth HDC, Hickey AJ, editors. Controlled Pulmonary Drug Delivery. Ch.2: Pulmonary Drug Metabolism, Clearance, and Absorption. New York: Springer; 2011. p 21–50.
3. Labiris NR, Dolovich MB. Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications: Physiological factors affecting the effectiveness of inhaled drugs. Br J Clin Pharmacol 2003;56:588–599.
4. Shah ND, Shah VV, Chivate ND. Pulmonary drug delivery: A promising approach. J Appl Pharm Sci 2012;2:33–37.
5. D'Agostino B, Sullo N, Siniscalco D, De Angelis A, Rossi F. Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease. Expert Opin Biol Ther 2010;10:681–687.
6. Weiss DJ, Casaburi R, Flannery R, LeRoux-Williams M, Tashkin DP. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD mesenchymal stem cells for COPD. Chest J 2013;143:1590–1598.
7. Wang D, Morales JE, Calame DG, Alcorn JL, Wetsel RA. Transplantation of human embryonic stem cell–derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol. Ther 2010;18:625–634.
8. Prockop DJ, Youn Oh J. Mesenchymal stem/stromal cells (MSCs): Role as guardians of inflammation. Mol Ther 2012;20:14–20.
9. Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF- B signaling in resident macrophages. Blood 2011;118:330–338.
10. Oh JY, Roddy G, Choi H, Lee RH, Ylostalo J, Rosa R, Prockop D. Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc Natl Acad Sci USA 2010;107:16875–16880.
11. Matthay MA, Goolaerts A, Howard JP, Woo Lee J. Mesenchymal stem cells for acute lung injury: Preclinical evidence. Crit Care Med 2010;38:S569–S573.
12. Lee JW, Gupta N, Serikov V, Matthay MA. Potential application of mesenchymal stem cells in acute lung injury. Expert Opin Biol Ther 2009;9:1259–1270.
13. Mei SH, McCarter S, Deng Y, Parker C, Liles C, Stewart D. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 2007;4:e269
14. Lee JW, Fang X, Gupta N, Serikov V, Matthay MA. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 2009;106:16357–16362.
15. Zhang WG, He L, Shi XM, Wu SS, Zhang B, Mei L, Xu YJ, Zhang ZX, Zhao JP, Zhang HL. Regulation of transplanted mesenchymal stem cells by the lung progenitor niche in rats with chronic obstructive pulmonary disease. Respir Res 2014;15:33
16. Stucky EC, Schloss RS, Yarmush ML, Shreiber DI. Alginate micro-encapsulation of mesenchymal stromal cells enhances modulation of the neuro-inflammatory response. Cytotherapy 2015;17:1353–1364.
17. Garate A, Tsai L, Murthy S, Tyagi S, Mazan M, Hoffman A. Assessment of the behavior of mesenchymal stem cells immobilized in biomimetic alginate microcapsules. Mol. Pharm 2015;12:3953–3962.
18. Lu S, Lee EJ, Lam J, Tabata Y, Mikos AG. Evaluation of Gelatin Microparticles as Adherent-Substrates for Mesenchymal Stem Cells in a Hydrogel Composite. Ann Biomed Eng. 2016. Epub ahead of print.
19. Ingenito EP. Autologous Lung-Derived Mesenchymal Stem Cell Transplantation in Experimental Emphysema. Cell Transplant 2012;21:175–189.
20. Badylak S, Freytes D, Gilbert T. Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomater 2009;5:1–13.
21. Daly AB. Initial binding and recellularization of decellularized mouse lung scaffolds with bone marrow-derived mesenchymal stromal cells. Tissue Eng Part A 2012;18:1–16.
22. French KM, Boopathy AV, DeQuach JA, Chingozha L, Lu H, Christman KL, Davis ME. A naturally derived cardiac extracellular matrix enhances cardiac progenitor cell behavior in vitro. Acta Biomater 2012;8:4357–4364.
23. Gilbert T, Sellaro T, Badylak S. Decellularization of tissues and organs. Biomaterials. 2006;27:3675–3683.
24. Hoshiba T, Lu H, Kawazoe N, Chen G. Decellularized matrices for tissue engineering. Expert Opin Biol Ther 2010;10:1717–1728.
25. Nichols JE, Niles JA, Cortiella J. Production and utilization of acellular lung scaffolds in tissue engineering. J Cell Biochem 2012;113:2185–2192.
26. Petersen TH, Calle EA, Colehour MB, Niklason LE. Matrix composition and mechanics of decellularized lung scaffolds. Cells Tissues Organs 2012;195:222–231.
27. Badylak SF, Valentin JE, Ravindra AK, McCabe GP, Stewart-Akers AM. Macrophage Phenotype as a Determinant of Biologic Scaffold Remodeling. Tissue Eng Part A 2008;14:1835–1842.
28. Badylak SF. The extracellular matrix as a biologic scaffold material⋆. Biomaterials 2007;28:3587–3593.
29. Valentin JE, Badylak JS, McCabe GP, Badylak SF. Extracellular matrix bioscaffolds for orthopaedic applications. J Bone Joint Surg Am 2006;88:2673–2686.
30. Bonvillain RW, Danchuk S, Sullivan DE, Betancourt AM, Semon JA, Eagle ME, Mayeux JP, Gregory AN, Wang G, Townley IK, Borg ZD, Weiss DJ, Bunnell BA. A Nonhuman Primate Model of Lung Regeneration: Detergent-Mediated Decellularization and Initial In Vitro Recellularization with Mesenchymal Stem Cells. Tissue Eng Part A 2012;18:2437–2452.
31. Johnson TD, Lin SY, Christman KL. Tailoring material properties of a nanofibrous extracellular matrix derived hydrogel. Nanotechnology 2011;22:494015
32. Singelyn JM, Sundaramurthy P, Johnson TD, Schup-Magoffin PJ, Hu DP, Faul DM, Wang J, Mayle KM, Bartels K, Salvatore M, Kinsey A, DeMaria AN, Dib N, Christman KL. Catheter-Deliverable Hydrogel Derived From Decellularized Ventricular Extracellular Matrix Increases Endogenous Cardiomyocytes and Preserves Cardiac Function Post-Myocardial Infarction. J Am Coll Cardiol 2012;59:751–763.
33. Kwon JS, Yoon SM, Shim SW, Park JH, Min KJ, Oh HJ, Kim JH, Kim YJ, Yoon JJ, Choi BH, Kim MS. Injectable extracellular matrix hydrogel developed using porcine articular cartilage. Int J Pharm 2013;454:183–191.
34. Wolf MT. A hydrogel derived from decellularized dermal extracellular matrix. Biomaterials 2012;33:7028–7038.
35. Young DA, Ibrahim DO, Hu D, Christman KL. Injectable hydrogel scaffold from decellularized human lipoaspirate. Acta Biomater 2011;7:1040–1049.
36. Freytes DO, Martin J, Velankar SS, Lee AS, Badylak SF. Preparation and rheological characterization of a gel form of the porcine urinary bladder matrix. Biomaterials 2008;29:1630–1637.
37. Medberry CJ, Crapo PM, Siu BF, Carruthers CA, Wolf MT, Nagarkar SP, Agrawal V, Jones KE, Kelly J, Johnson SA, Velankar SS, Watkins SC, Modo M, Badylak SF. Hydrogels derived from central nervous system extracellular matrix. Biomaterials 2013;34:1033–1040.
38. Seif-Naraghi SB, Horn D, Schup-Magoffin PJ, Christman KL. Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor. Acta Biomater 2012;8:3695–3703.
39. Price AP, England KA, Matson AM, Blazar BR, Panoskaltsis-Mortari A. Development of a decellularized lung bioreactor system for bioengineering the lung: The matrix reloaded. Tissue Eng Part A 2010;16:2581–2591.
40. Price AP, Godin LM, Domek A, Cotter T, D'Cunha J, Taylor DA, Panoskaltsis-Mortari A. Automated decellularization of intact, human-sized lungs for tissue engineering. Tissue Eng Part C Methods. 2015;21:94–103.
41. Wagner DE, Bonenfant NR, Parsons CS, Sokocevic D, Brooks EM, Borg ZD, Lathrop MJ, Wallis JD, Daly AB, Lam YW, Deng B, DeSarno MJ, Ashikaga T, Loi R, Weiss DJ. Comparative decellularization and recellularization of normal versus emphysematous human lungs. Biomaterials 2014;35:3281–3297.
42. Long JL, Tranquillo RT. Elastic fiber production in cardiovascular tissue-equivalents. Matrix Biol 2003;22:339–350.
43. Frazier SB, Roodhouse KA, Hourcade DE, Zhang L. The Quantification of Glycosaminoglycans: A Comparison of HPLC, Carbazole, and Alcian Blue Methods. Open Glycosci 2008;1:31–39.
44. Saluja B, Li H, Desai UR, Voelkel NF, Sakagami M. Sulfated Caffeic Acid Dehydropolymer Attenuates Elastase and Cigarette Smoke Extract–induced Emphysema in Rats: Sustained Activity and a Need of Pulmonary Delivery. Lung 2014;192:481–492.
45. Macher BA, Galili U. The Galα1,3Galβ1,4GlcNAc-R (α-Gal) epitope: A carbohydrate of unique evolution and clinical relevance. Biochim Biophys Acta 2008;1780:75–88.
46. Goldblum SE, Wu KM, Jay M. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J Appl Physiol 1985;59:1978–1985.
47. Badylak SF. Decellularized allogeneic and xenogeneic tissue as a bioscaffold for regenerative medicine: Factors that influence the host response. Ann Biomed Eng 2014;42:1517–1527.
48. Naso F, Gandaglia A, Iop L, Spina M, Gerosa G. First quantitative assay of alpha-Gal in soft tissues: Presence and distribution of the epitope before and after cell removal from xenogeneic heart valves. Acta Biomater 2011;7:1728–1734.
49. Wallis JM, Borg ZD, Daly AB, Deng B, Ballif BA, Allen GB, Jaworski DM, Weiss DJ. Comparative assessment of detergent-based protocols for mouse lung de-cellularization and re-cellularization. Tissue Eng Part C Methods 2012;18:420–432.
50. Gilbert TW, Daly KA, Brennan-Pierce EP, Johnson SA, Carruthers CA, D'Amore A, Nagarkar SP, Velankar SS, Badylak SF. Strategies for tissue and organ decellularization. J Cell Biochem 2012;113:2217–2222.
51. Butcher DT, Alliston T, Weaver VM. A tense situation: forcing tumour progression. Nat Rev Cancer 2009;9:108–122.
52. Singelyn JM, Christman KL. Modulation of Material Properties of a Decellularized Myocardial Matrix Scaffold. Macromol Biosci 2011;11:731–738.
53. Brennan EP, Reing J, Chew D, Myers-Irvin JM, Young EJ, Badylak SF. Antibacterial Activity within Degradation Products of Biological Scaffolds Composed of Extracellular Matrix. Tissue Eng 2006;12:2949–2955.
54. Reing JE, Zhang L, Myers-Irvin J, Cordero KE, Freytes DO, Heber-Katz E, Bedelbaeva K, McIntosh D, Dewilde A, Braunhut SJ. Degradation products of extracellular matrix affect cell migration and proliferation. Tissue Eng Part A 2008;15:605–614.
55. Wagner DE, Bonvillain RW, Jensen T, Girard ED, Bunnell BA, Finck CM, Hoffman AM, Weiss DJ. Can stem cells be used to generate new lungs? Ex vivo lung bioengineering with decellularized whole lung scaffolds: Ex vivo lung bioengineering. Respirology 2013;18:895–911.
56. Badylak SF, Taylor D, Uygun K. Whole-organ tissue engineering: Decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng 2011;13:27–53.
57. Singelyn JM, DeQuach JA, Seif-Naraghi SB, Littlefield RB, Schup-Magoffin PJ, Christman KL. Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Biomaterials 2009;30:5409–5416.